Status:
UNKNOWN
Intraoperative MRI and 5-ALA Guidance to Improve the Extent of Resection in Brain Tumor Surgery
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Conditions:
Primary Malignant Neoplasm of Nervous System
Glioma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators hypothesize that the rate of radiologically complete resections of contrast-enhancing brain tumors following surgeries aided by use of 5-ALA induced fluorescence guidance and use of ...
Eligibility Criteria
Inclusion
- adult patient (\> 18 years) able to give informed consent
- primary supratentorial intra-axial brain tumor exhibiting contrast enhancement suspected to be malignant glioma
- tumor must be deemed completely resectable by neurosurgeon
- diagnostic MRI
Exclusion
- patient unable or unwilling to give informed consent
- infratentorial tumor location
- tumor location in or near eloquent areas
- multifocal tumor
- existance of contraindications to undergo MRI examination
- previous surgical treatment for an intraaxial brain tumor
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2016
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT01798771
Start Date
March 1 2013
End Date
February 1 2016
Last Update
February 26 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinik für Neurochirurgie Johann Wolfgang Goethe University
Frankfurt am Main, Hesse, Germany, 60528